Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis.

Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis. Abstract Text:

    izumi kikuchiIzumi Kikuchi,hiroyuki tanumaHiroyuki Tanuma,kensuke morimotoKensuke Morimoto,seiji kawanaSeiji Kawana,

    To study and establish an optimal administration method of oral antifungal, terbinafine (TBF), for hyperkeratotic type tinea pedis, from the pharmacokinetic point of view, 20 patients with hyperkeratotic type tinea pedis were given TBF 125 mg once daily for 4 weeks and observed over time for improvement in dermatological symptoms and mycological efficacy. Targeting five of the patients, TBF concentration in the stratum corneum was measured using the liquid chromatography/tandem mass spectrometry (LC-MS/MS) method. TBF was detected in the stratum corneum of the sole 1 week after beginning the treatment in some cases and reached its peak 1 week after the completion of the treatment with a concentration of 247.8 ng g(-1), which was approximately more than 50 times higher than its minimal inhibitory concentration against dermatophytes. TBF was not detected at 8 weeks post-treatment, although its concentration was 50.73 ng g(-1) at 6 weeks post-treatment. Its effectiveness rate (effective + markedly effective) was 95% (19/20) with no adverse reactions, including abnormal changes in the laboratory test values, in any patient. These results suggest that TBF is a useful drug to treat hyperkeratotic tinea pedis from the pharmacokinetic point of view.

    Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis. Publishing Authors By Initials

    i kikuchiI Kikuchi,h tanumaH Tanuma,k morimotoK Morimoto,s kawanaS Kawana,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Mycoses

    VOLUME: 51

    Page Numbers: 7-13

    Journal Abbreviation: Mycoses

    ISSN: 0933-7407

    DAY: 13

    MONTH: Jan

    YEAR: 2008

    Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8805008

    Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis.

    AFFILIATION: Department of Dermatology, Nippon Medical School, Tokyo, Japan, and Aidu Chuo Hospital, Fukushima, Japan.

    Country: Germany

    Germany Research PublicationGermany Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Mycoses

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News